Article
The Bioavailability Toolbox
Scientists now have an arsenal of drug delivery techniques to choose from.
View Now
Offering Fact Sheet
OptiGel Mini Technology
Deliver higher API concentrations in smaller capsules for patient benefits.
View Now
Presentation
AAPS 2014 with Pharmaceutical Outsourcing
OptiPact™ Technology, capabilities for Orphan Drugs & Catalent's factors of differentiation.
View Now
Case Study
OptiGel Bio Enables Delivery of Synthetic Oligosaccharides
Macromolecules can potentially be converted from injectable to oral drug delivery.
View Now
Webinars
Optimize Your Oral Drug Development Pathway
Learn about how softgel technologies can address API and processing challenges.
View Now
Webinars
New Formulation and Delivery Technology is Unlocking Profit
Learn more about integrating formulation technology in drug development.
View Now
Article
Lipid-Based Delivery of Peptide Therapeutics
An explanation of OptiGel Bio™ technology as a delivery tool for macromolecule NCE candidates.
View Now
Presentation
Conversion from LFHS to RP Scherer Softgel Capsules
RP Scherer Technology can improve timelines and commercialization potential.
View Now
Presentation
Strategies for Orphan, Breakthrough and Fast Track Programs
Learn about Orphan drug development and other fast track product development pathways.
View Now
Poster
OptiShell® Technology Capsule Innovations
New shell and hot-filling that are highly viscous or semi-solid at room temperature
View Now
